PTC Therapeutics Inc at JPMorgan Healthcare Conference Transcript
All right, great. We'll get started here. I'm Eric Joseph, senior biotech analyst at JPMorgan. And our next presenting company is PTC Therapeutics. It's my pleasure to introduce Stuart Peltz to tell us a little bit about the company. Before we begin, I just want to remind the audience that the breakout session, the breakout Q&A is going to be across the hall in the Georgian room. With that, Stu?
Okay. Well, thank you all, both here and on the web, for coming today. And what I want to do is just tell you about PTC. We will be making some forward-looking statements, so I'll refer you to our SEC filings. So I thought I'd start to say, who are we? We're a global commercial diversified biopharmaceutical company that's focused on innovative therapies for rare genetic disorders.
And I thought what I'd do today is to dissect that for you a bit, break it down. So you understand the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
